Surmodics Reports Second Quarter of Fiscal Year 2024 Financial Results; Updates Fiscal Year 2024 Financial Guidance [Yahoo! Finance]
Surmodics, Inc. (SRDX)
Last surmodics, inc. earnings: 4/29 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
surmodics.gcs-web.com/investor-overview
Company Research
Source: Yahoo! Finance
EDEN PRAIRIE, Minn., May 01, 2024 BUSINESS WIRE )--Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today reported financial results for its second quarter ended March 31, 2024, and updated financial guidance for its fiscal year ending September 30, 2024. Second Quarter Fiscal 2024 Financial Summary Total Revenue of $32.0 million, an increase of 18% year-over-year Total Revenue excluding SurVeil™ drug-coated balloon ("DCB") license fee revenue of $30.9 million, an increase of 19% year-over-year GAAP net income of $0.2 million, compared to a net loss of $(7.7) million in the prior-year period Adjusted EBITDA of $4.8 million, compared to $(1.5) million in the prior-year period Second Quarter and Recent Business Highlights On January 22, 2024, Surmodics announced the successful early clinical use and limited market evaluation (LME) of the Pounce LP (Low Profile) Thrombectomy System, which
Show less
Read more
Impact Snapshot
Event Time:
SRDX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SRDX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SRDX alerts
High impacting Surmodics, Inc. news events
Weekly update
A roundup of the hottest topics
SRDX
News
- Surmodics, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next [Yahoo! Finance]Yahoo! Finance
- Surmodics (SRDX) Q2 Earnings Top Estimates, '24 View Up [Yahoo! Finance]Yahoo! Finance
- Surmodics, Inc. (NASDAQ: SRDX) had its "outperform" rating re-affirmed by analysts at Barrington Research. They now have a $71.00 price target on the stock.MarketBeat
- Surmodics, Inc. (NASDAQ: SRDX) had its price target lowered by analysts at Needham & Company LLC from $47.00 to $43.00. They now have a "buy" rating on the stock.MarketBeat
- SurModics (SRDX) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates [Yahoo! Finance]Yahoo! Finance
SRDX
Earnings
- 5/1/24 - Beat
SRDX
Sec Filings
- 5/1/24 - Form 10-Q
- 5/1/24 - Form 8-K
- SRDX's page on the SEC website